Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun;135(6):e136.
doi: 10.1016/j.amjmed.2022.02.004.

COVID-19 and Light Chain Amyloidosis: Correspondence

Rujittika Mungmunpuntipantip  1 , Viroj Wiwanitkit  2
Affiliations
Comment

COVID-19 and Light Chain Amyloidosis: Correspondence

Rujittika Mungmunpuntipantip et al. Am J Med. 2022 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Crees ZD, Stockerl-Goldstein K. COVID-19 and light chain amyloidosis, adding insult to injury [Online ahead of print] Am J Med. 2022 Jan 23 doi: 10.1016/j.amjmed.2022.01.005. - DOI - PMC - PubMed
    1. Mungmungpuntipantip R, Wiwanitkit V. COVID-19 vaccination in oncology patients receiving chemotherapy. Clin Oncol (R Coll Radiol) 2021;33(10):e467. - PMC - PubMed
    1. Isobe T, Takatsuki K, Tishendorf FW, Birken S, Osserman EF. Plasma cell myeloma, hyperviscosity and amyloidosis associated with a serum IgG3 lambda and urinary excretion of two fragments related to the variable portion of lambda light chains. Clin Immunol Immunopathol. 1981;19(1):55–66. - PubMed
    1. Joob B, Wiwanitkit V. Expected viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19. Clin Appl Thromb Hemost. 2021;27 - PMC - PubMed
    1. Joob B, Wiwanitkit V. Blood viscosity of COVID-19 patient: a preliminary report. Am J Blood Res. 2021;11(1):93–95. - PMC - PubMed